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1. Introduction 
The microsomal heme oxygenase system, which 
catalyzes the oxidative degradation of protoheme to 
biliverdin IXol, consists of heme oxygenase (EC 
1.14.99.3) and NADPH-cytochrome c reductase (EC 
1.6.2.4; fpT). With microsomes, however, the heme 
oxygenase reaction is also supported by NADH [I]. 
In this case, however, NADH may serve as electron 
donor by way of fpT [2,3]. In fact, we demonstrated 
that the NADH-cytochrome b5 reductase system, 
which was reconstituted from NADH-cytochrome bS 
reductase (EC 1.6.2.2, fpD and cytochrome b5 par- 
tially purified from rat liver microsomes, failed to 
support the heme degradation to form biliverdin IXa 
from the heme . heme oxygenase complex, although 
the reconstituted fp,, system could effectively reduce 
the heme bound to the heme oxygenase, using NADH 
as electron donor [3]. The reason why the fpD system 
could not support the biliverdin formation has 
remained unsolved. 
On the other hand, recently we obtained an oxy- 
genated form of the heme - heme oxygenase complex 
and revealed that a reducing equivalent was indis- 
pensable for the onset of heme degradation from 
the oxygenated form of the complex [4]. Therefore, 
the possibility arises that the fpD system may hardly 
be able to donate electron to the oxygenated form of 
the heme . heme oxygenase complex to initiate the 
heme degradation leading to the formation of biliver- 
din 1Xc~. The present study has revealed that this is 
really the case. 
2. Materials and methods 
Heme oxygenase was purified from pig spleen 
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microsomes [5] and the complex of ferric heme and 
heme oxygenase was prepared as in [5]. fpT [5], fpD 
[6], and cytochrome b5 [7] were partially purified 
from pig liver microsomes by the method referred. 
The fpT preparation was free from either of cyto- 
chrome b5 and fpD, and the fpD preparation was free 
from cytochrome b5 and fpT. Activity of fpT was 
determined by reduction of horse heart cytochrome c 
(purchased from Sigma) in 2 ml system [8], and 1 unit 
of fpT was defined as the amount of enzyme cata- 
lyzing the reduction of 1 pmol of cytochrome c (cyt. 
c-unit)/min at 25°C. Activity of fpD was determined 
by reduction of 2,6-dichlorophenolindophenol and 1 
dye-unit was defined as the amount of enzyme cata- 
lyzing the reduction of 1 pmol dye/min at 25°C [8]. 
Activity of the fpD system was determined by reduc- 
tion of cytochrome c in the presense of cytochrome b5 
(cyt. c-unit); 0.02 cyt. c-unit of the fpD system con- 
sisted of -0.14 dye-unit of fpD and 0.25 nmol cyto- 
chrome b5 under our experimental conditions. The 
amount of cytochrome b5 was determined by mea- 
suring the a-band of reduced form of cytochrome bs 
[9]. Highly purified biliverdin reductase was obtained 
from the soluble fraction of pig spleen [IO]. Solution 
A was a mixture of 1 mM EDTA, 0.1% Triton X-100, 
and 0.1% sodium cholate. Chemicals were obtained 
from commercial sources described in [5,11]. 
3. Results 
3.1. Comparison of rates of reduction of the heme 
bound to heme oxygenase by the fpT system, the 
fpD system and fpD 
The reaction was carried out in a Thunberg-type 
cuvette filled with CO gas, employing -0.02 cyt. 
Elsevier/North-Holland Biomedical Press 
Volume 115, number 2 FEBS LETTERS June 1980 
c-unit of respective reductases and 5.5 nmol heme of 
the ferric heme . heme oxygenase complex, in 2 ml 
final vol. Reaction was started by introducing NADPH 
or NADH, and the increase A4s1 was recorded. With 
the fpT system, the half-reduction time of ferric 
heme . heme oxygenase complex was -150 s, while it 
was -435 s with the fpl, system. When cytochrome 
bs was omitted from the fpD system, the half-reduc- 
tion time was >1500 s. These results are consistent 
with our observations with preparations from rat liver 
microsomes. 
WAVELENGTH (nm) 
3.2. Heme oxygenase reaction with. the fpD system 
We reported that the oxygenated heme bound to 
heme oxygenase was readily and quantitatively con- 
verted to biliverdin IXCY when the oxygenated 
heme . heme oxygenase complex was incubated with 
the fpT system [4]. However, when the fpr, system 
was used in place of the fpT system, the absorption of 
the oxygenated form of the complex (curve I in fig.1) 
only decreased slowly, maintaining a spectrum 
characteristic of the oxygenated complex. Curve III 
represents an absorption spectrum recorded -1 h 
after the start of the reaction. Also no bilirubin was 
formed when biliverdin reductase and NADPH were 
added to the incubation mixture giving curve III; 
further addition of desferrioxamine, a ferric iron 
chelator, exerted no effect (data not shown; cf. [ 1 I]). 
These observations indicate that neither biliverdin 
IXo nor biliverdin-iron chelate was formed by incu- 
bation with the fpD system and some nonspecific 
heme degradation occurred in this reaction system. 
In an experiment the ferric heme . heme oxygen- 
ase complex was incubated with the fpD system in air. 
As shown in fig.2, the absorption in the Soret region 
of the ferric form of the complex decreased, and the 
peak shifted to longer wavelength side and finally 
settled at 412 nm. In the visible region two absorp- 
tion peaks around 540 and 575 nm became distinct 
with the time of incubation. The absorption spectrum 
depicted by curve II in fig.2 closely resembles that of 
curve I in fig. 1 which represents an oxygenated form 
of the heme . heme oxygenase complex (cf. [4]). 
These observations indicate that the ferric heme 
bound to heme oxygenase was first reduced by the 
fpD system to the ferrous state, followed by binding 
with molecular oxygen to form the oxygenated 
heme . heme oxygenase complex. With the fpT 
system, we failed to observe an oxygenated form of 
the complex during the reaction [ 1 l] probably 
Fig.1. Reaction with the oxygenated heme bound to heme 
oxygenase and the fpD system. Sample cuvette contained, in 
2 ml final vol., - 1.6 PM heme of the oxygenated form of 
heme * heme oxygenase complex and 0.2 mg bovine serum 
albumin in 110 mM potassium phosphate buffer (pH 7.4) 
containing solution A. The complex was omitted in the 
reference cuvette. Then, 0.02 cyt. c-unit of the fpD system 
(0.05 ml) and 0.05 ml 2 mM NADH were added to both 
cuvettes and the spectral change was followed at 25°C. Curve I, 
the oxygenated form of the complex; curve II, 10 min after 
the start of the reaction; curve III, 1 h after the start of the 
reaction. For comparison, in an independent experiment, 
0.02 cyt. c-unit of fpT (0.025 ml), excess of highly purified 
biliverdin reductase (0.025 ml) and 0.05 ml 2 mM NADPH 
were added to a mixture showing curve I, and the absorption 
spectrum of the final product (bilirubin) is depicted by 
dotted line. 
Fig.2. Reaction with the ferric heme bound to heme oxygen- 
ase and the fpD system in air. Sample cuvette contained, in 
2 ml final vol., -3.4 PM heme of the ferric form of the com- 
plex in 110 mM potassium phosphate buffer (pH 7.4) con- 
taining solution A. The complex was omitted in the reference 
cuvette. Temp., 25°C. Curve I, the ferric form of the com- 
plex; curve II, 30 min after the addition of 0.02 cyt. c-unit of 
the fpD system (0.05 ml) and 0.05 ml 2 mM NADH to both 
cuvettes; curve III, 90 min after the start of the reaction. 
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because the heme, once oxygenated, israpidly decom- 
posed to biliverdin in this reaction system. 
To account for the observation that the fpD system 
could not serve as electron donor system in the heme 
oxygenase reaction, we had suspected the possibility 
that the fpD system might cause some conformational 
change of the heme oxygenase protein so as to lose 
the stereospecificity of heme oxidation. To test this 
possibihty, we examined the effects of additions of 
fpD (0.14 dye-unit), fpD plus cytochrome bs 
(0.25 nmol), and fpD plus cytochrome bs plus 
NADH (100 nmol), respectively, on the rate of heme 
degradation i the reaction system containing 1.6 FM 
heme of the ferric heme - heme oxygenase complex, 
fpT (0.02 cyt. c-unit), and NADPH (100 nmol), in 
2 ml final vol. in all systems tested, however, the time 
required for degradation of half the amount of heme 
used, as measured by decrease inAN5 at 25°C was 
240 s, indicating that the fpT-supported heme 
degradation was not affected at all by the simulta- 
neous presence of any component of the fpD system. 
4. Discussion 
It is ~teresting that the fpD system could donate 
few electrons to the oxygenated form of heme - heme 
oxygenase complex to initiate heme degradation 
leading to the formation of biliverdin IX&, while it 
could effectively reduce the ferric form of the com- 
plex. With the fpD system, the oxygenated heme 
slowly underwent nonspeci~c degradation to some 
unknown product(s), possibly by the action of HaOa 
formed during the incubation with the fpD system 
[ 12,131. Also the fp,, system did not affect at all the 
fp+upported heme oxygenase reaction. We may con- 
clude that the microsomal heme oxygenase isstrictly 
linked with the fpT system in the physiological heme 
degradation. It is also worth noting that the oxygen- 
ated form of heme . heme oxygenase complex was 
formed when the ferric heme . heme oxygenase com- 
plex was incubated with the fpD system. These obser- 
vations upport findings [4j that heme degradation 
starts from the oxygenated form of the complex and 
that a reducing equivalent is indispensable for the 
onset of heme degradation. 
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